Lindsey McClelland

Chief Operating Officer at Oxeia Biopharmaceuticals, Inc.

Health Technology

Health Services

Consumer Services

Profile

Lindsey McClelland is currently the Vice President-Operations at Oxeia Biopharmaceuticals, Inc. Prior to this, Lindsey worked as the Director-Program Management at Onebiopharma, Inc. Lindsey's education includes an undergraduate degree from Boston College.

Lindsey McClelland active positions

Companies	Position	Start
Oxeia Biopharmaceuticals, Inc. Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA.	Chief Operating Officer	2021-10-31

All active positions of Lindsey McClelland

Former positions of Lindsey McClelland

Companies	Position	End
Onebiopharma, Inc. Onebiopharma, Inc. Medical/Nursing ServicesHealth Services Onebiopharma, Inc. provides health care services. The company is headquartered in Boston, MA.	Corporate Officer/Principal	-

See the detail of Lindsey McClelland's experience

Training of Lindsey McClelland

Boston College

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Lindsey McClelland's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Oxeia Biopharmaceuticals, Inc. Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA.	Health Technology
Onebiopharma, Inc. Onebiopharma, Inc. Medical/Nursing ServicesHealth Services Onebiopharma, Inc. provides health care services. The company is headquartered in Boston, MA.	Health Services